Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced/Metastatic Solid Tumors × mogamulizumab × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor 1 Advanced/Metastatic Solid Tumors 1 Advanced Solid Tumors 1

Interventions

pembrolizumab 2 utomilumab 1 trifluridine tipiracil drug combination 1 mogamulizumab 1 Trifluridine 1 Standard of Care 1 N-(6,6-dimethyl-5-((1-methylpiperidin-4-yl)carbonyl)-1,4,5,6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-methylbutanamide 1 Injections 1 HMPL-013 1 Fulvestrant 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02444793 2019-02-27

A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors

Pfizer

Phase 1 Terminated

24 enrolled 34 charts

Other solid neoplasm

Advanced/Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡